Brinker Capital Investments, LLC Catalent, Inc. Transaction History

Brinker Capital Investments, LLC

$83.4 Billion
Q2 2025

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Jul 31, 2025	SELL	$56.16 - $60.96 $752,880 - $817,229	-13,406 Closed	0 $0
Q2 2024 Jul 31, 2025	SELL	$53.58 - $57.02 $2.18 Million - $2.32 Million	-40,770 Reduced 75.25%	13,406 $753,000
Q1 2024 Jul 31, 2025	SELL	$42.56 - $59.82 $694,238 - $975,783	-16,312 Reduced 23.14%	54,176 $3.06 Million
Q4 2023 Jul 31, 2025	BUY	$32.18 - $46.57 $336,699 - $487,261	10,463 Added 17.43%	70,488 $3.17 Million
Q3 2023 Jul 31, 2025	SELL	$44.2 - $50.2 $265,730 - $301,802	-6,012 Reduced 9.1%	60,025 $2.73 Million
Q2 2023 Jul 31, 2025	SELL	$31.86 - $67.26 $947,994 - $2 Million	-29,755 Reduced 31.06%	66,037 $2.86 Million
Q1 2023 Jul 31, 2025	SELL	$45.44 - $74.26 $236,469 - $386,449	-5,204 Reduced 5.15%	95,792 $6.29 Million
Q4 2022 Feb 06, 2023	BUY	$41.39 - $81.0 $205,501 - $402,165	4,965 Added 5.17%	100,996 $4.54 Million
Q3 2022 Nov 01, 2022	SELL	$72.36 - $113.1 $609,850 - $953,206	-8,428 Reduced 8.07%	96,031 $6.95 Million
Q2 2022 Jul 18, 2022	BUY	$87.2 - $114.05 $371,995 - $486,537	4,266 Added 4.26%	104,459 $11.2 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $1.06 Million - $1.4 Million	-11,212 Reduced 10.06%	100,193 $11.1 Million
Q4 2021 Feb 08, 2022	SELL	$119.57 - $139.07 $2.59 Million - $3.01 Million	-21,671 Reduced 16.28%	111,405 $14.3 Million
Q2 2021 Aug 03, 2021	BUY	$100.34 - $115.69 $12.9 Million - $14.9 Million	128,598 Added 2871.77%	133,076 $14.4 Million
Q1 2021 May 12, 2021	SELL	$101.51 - $125.27 $21.2 Million - $26.2 Million	-208,866 Reduced 97.9%	4,478 $472,000
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $11 Million - $13.4 Million	127,612 Added 148.85%	213,344 $22.2 Million
Q3 2020 Dec 03, 2020	BUY	$72.74 - $92.5 $6.24 Million - $7.93 Million	85,732 New	85,732 $7.34 Million

Others Institutions Holding CTLT

# of Institutions

Shares Held

16.5M

Call Options Held

10.7K

Put Options Held

4.5K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account